269 related articles for article (PubMed ID: 20125003)
1. Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis.
Drager LF; Jun J; Polotsky VY
Curr Opin Endocrinol Diabetes Obes; 2010 Apr; 17(2):161-5. PubMed ID: 20125003
[TBL] [Abstract][Full Text] [Related]
2. Obstructive sleep apnea and dyslipidemia: from animal models to clinical evidence.
Barros D; García-Río F
Sleep; 2019 Mar; 42(3):. PubMed ID: 30476296
[TBL] [Abstract][Full Text] [Related]
3. Effect of deficiency in SREBP cleavage-activating protein on lipid metabolism during intermittent hypoxia.
Li J; Nanayakkara A; Jun J; Savransky V; Polotsky VY
Physiol Genomics; 2007 Oct; 31(2):273-80. PubMed ID: 17666524
[TBL] [Abstract][Full Text] [Related]
4. Dyslipidemia and atherosclerosis induced by chronic intermittent hypoxia are attenuated by deficiency of stearoyl coenzyme A desaturase.
Savransky V; Jun J; Li J; Nanayakkara A; Fonti S; Moser AB; Steele KE; Schweitzer MA; Patil SP; Bhanot S; Schwartz AR; Polotsky VY
Circ Res; 2008 Nov; 103(10):1173-80. PubMed ID: 18832746
[TBL] [Abstract][Full Text] [Related]
5. Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apnea.
Drager LF; Jun JC; Polotsky VY
Best Pract Res Clin Endocrinol Metab; 2010 Oct; 24(5):843-51. PubMed ID: 21112030
[TBL] [Abstract][Full Text] [Related]
6. Intermittent hypoxia and hypercapnia induce pulmonary artery atherosclerosis and ventricular dysfunction in low density lipoprotein receptor deficient mice.
Douglas RM; Bowden K; Pattison J; Peterson AB; Juliano J; Dalton ND; Gu Y; Alvarez E; Imamura T; Peterson KL; Witztum JL; Haddad GG; Li AC
J Appl Physiol (1985); 2013 Dec; 115(11):1694-704. PubMed ID: 23990245
[TBL] [Abstract][Full Text] [Related]
7. Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice.
Li J; Grigoryev DN; Ye SQ; Thorne L; Schwartz AR; Smith PL; O'Donnell CP; Polotsky VY
J Appl Physiol (1985); 2005 Nov; 99(5):1643-8. PubMed ID: 16037401
[TBL] [Abstract][Full Text] [Related]
8. Intermittent hypoxia induces hyperlipidemia in lean mice.
Li J; Thorne LN; Punjabi NM; Sun CK; Schwartz AR; Smith PL; Marino RL; Rodriguez A; Hubbard WC; O'Donnell CP; Polotsky VY
Circ Res; 2005 Sep; 97(7):698-706. PubMed ID: 16123334
[TBL] [Abstract][Full Text] [Related]
9. Effect of obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis.
Nadeem R; Singh M; Nida M; Waheed I; Khan A; Ahmed S; Naseem J; Champeau D
J Clin Sleep Med; 2014 May; 10(5):475-89. PubMed ID: 24910548
[TBL] [Abstract][Full Text] [Related]
10. Could non-HDL-cholesterol be a better marker of atherogenic dyslipidemia in obstructive sleep apnea?
Basoglu OK; Tasbakan MS; Kayikcioglu M
Sleep Med; 2021 Dec; 88():29-35. PubMed ID: 34731825
[TBL] [Abstract][Full Text] [Related]
11. Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism.
Adedayo AM; Olafiranye O; Smith D; Hill A; Zizi F; Brown C; Jean-Louis G
Sleep Breath; 2014 Mar; 18(1):13-8. PubMed ID: 22903801
[TBL] [Abstract][Full Text] [Related]
12. Abnormalities of lipoprotein concentrations in obstructive sleep apnea are related to insulin resistance.
Liu A; Cardell J; Ariel D; Lamendola C; Abbasi F; Kim SH; Holmes TH; Tomasso V; Mojaddidi H; Grove K; Kushida CA; Reaven GM
Sleep; 2015 May; 38(5):793-9. PubMed ID: 25348129
[TBL] [Abstract][Full Text] [Related]
13. Chronic intermittent hypoxia induces atherosclerosis.
Savransky V; Nanayakkara A; Li J; Bevans S; Smith PL; Rodriguez A; Polotsky VY
Am J Respir Crit Care Med; 2007 Jun; 175(12):1290-7. PubMed ID: 17332479
[TBL] [Abstract][Full Text] [Related]
14. Obstructive sleep apnea, immuno-inflammation, and atherosclerosis.
Arnaud C; Dematteis M; Pepin JL; Baguet JP; Lévy P
Semin Immunopathol; 2009 Jun; 31(1):113-25. PubMed ID: 19404644
[TBL] [Abstract][Full Text] [Related]
15. Cysteinyl-leukotriene pathway as a new therapeutic target for the treatment of atherosclerosis related to obstructive sleep apnea syndrome.
Gautier-Veyret E; Bäck M; Arnaud C; Belaïdi E; Tamisier R; Lévy P; Arnol N; Perrin M; Pépin JL; Stanke-Labesque F
Pharmacol Res; 2018 Aug; 134():311-319. PubMed ID: 29920371
[TBL] [Abstract][Full Text] [Related]
16. Could the thromboxane A2 pathway be a therapeutic target for the treatment of obstructive sleep apnea-induced atherosclerosis?
Gautier-Veyret E; Van Noolen L; Lévy P; Pepin JL; Stanke-Labesque F
Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):97-104. PubMed ID: 26026712
[TBL] [Abstract][Full Text] [Related]
17. Chronic intermittent hypoxia induces atherosclerosis via activation of adipose angiopoietin-like 4.
Drager LF; Yao Q; Hernandez KL; Shin MK; Bevans-Fonti S; Gay J; Sussan TE; Jun JC; Myers AC; Olivecrona G; Schwartz AR; Halberg N; Scherer PE; Semenza GL; Powell DR; Polotsky VY
Am J Respir Crit Care Med; 2013 Jul; 188(2):240-8. PubMed ID: 23328524
[TBL] [Abstract][Full Text] [Related]
18. Independent Association between Sleep Fragmentation and Dyslipidemia in Patients with Obstructive Sleep Apnea.
Qian Y; Yi H; Zou J; Meng L; Tang X; Zhu H; Yu D; Zhou H; Su K; Guan J; Yin S
Sci Rep; 2016 May; 6():26089. PubMed ID: 27184822
[TBL] [Abstract][Full Text] [Related]
19. Obstructive sleep apnea and atherosclerosis.
Lévy P; Pépin JL; Arnaud C; Baguet JP; Dematteis M; Mach F
Prog Cardiovasc Dis; 2009; 51(5):400-10. PubMed ID: 19249446
[TBL] [Abstract][Full Text] [Related]
20. Obstructive sleep apnea: an emerging risk factor for atherosclerosis.
Drager LF; Polotsky VY; Lorenzi-Filho G
Chest; 2011 Aug; 140(2):534-542. PubMed ID: 21813534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
